LGN Form 4: Director Kelly Christie B. granted 5,357 RSUs

Rhea-AI Filing Summary

Legence Corp. director Kelly Christie B. received an award of 5,357 Restricted Stock Units (RSUs) on 09/15/2025. Each RSU converts to one share of the issuer's Class A common stock upon vesting, with the RSUs reported as acquired at a $0 price and leaving the reporting person with 5,357 shares beneficially owned after the transaction. The RSUs will fully vest on the earlier of the first anniversary of the award and the day before the issuer's 2026 annual stockholder meeting, and vesting is subject to continued service through that date.

Insights

Corporate Governance Expert

TL;DR: Director awarded 5,357 RSUs that vest by the 2026 annual meeting, aligning pay with future service.

The Form 4 discloses a standard equity-based director award: 5,357 Restricted Stock Units granted 09/15/2025, each converting to one Class A share on vesting. Vesting is tied to continued service and a near-term time-based milestone (one-year anniversary or immediately before the 2026 annual meeting), which is a typical retention and alignment mechanism for board members. The grant is recorded at $0 price, consistent with restricted awards rather than open-market purchases. The filing is informational and routine unless aggregated grants materially change insider ownership.

Securities Analyst

TL;DR: Transaction is routine director compensation; no cash consideration and modest share amount reported.

The report shows acquisition of 5,357 RSUs with an effective acquisition date of 09/15/2025 and zero purchase price, indicating compensation rather than market purchase. The RSUs convert to Class A common stock on vesting and are subject to time-based vesting tied to continued service. From an investor-impact perspective, this is a routine disclosure of insider compensation that does not by itself provide new operating or financial performance information.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Kelly Christie B.

(Last) (First) (Middle)

C/O LEGENCE CORP.

1601 LAS PLUMAS AVENUE

(Street)

SAN JOSE CA 95133

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Legence Corp. [ LGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	09/15/2025		A		5,357	A	$0	5,357	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive one share of Legence Corp.'s (the "Issuer") Class A common stock, par value $0.01 per share, upon vesting. The Restricted Stock Units will fully vest on the earlier of the first anniversary of the date of the award and the day immediately preceding the Issuer's 2026 annual stockholder meeting, subject to continued service through such date.

	/s/ Bryce Seki, as attorney-in-fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.